Prenatal and Newborn Immunoglobulin Levels from Mother-Child Pairs and Risk of Autism Spectrum Disorders

Background: An etiological role for immune factors operating during early brain development in children with autism spectrum disorders (ASD) has not yet been established. A major obstacle has been the lack of early biologic specimens that can be linked to later diagnosis. In a prior study, we found lower risk of ASD associated with higher levels of maternally-derived total IgG and Toxoplasmosis gondii (Toxo) IgG in newborn blood spot specimens from children later diagnosed with ASD compared to population controls. Methods: We obtained maternal mid-gestational serum specimens and newborn screening blood spots from the California Genetics Disease Screening Program (GDSP) for linked mother-baby pairs for 84 children with ASD and 49 children with developmental delay but not ASD (DD) identified from California Department of Developmental Services records and for 159 population controls sampled from birth certificates.Immunoglobulin levels in maternal and newborn specimens were measured by solid phase immunoassays and analyzed in logistic regression models for total IgG, total IgM, and Toxo IgG, and, for maternal specimens only, Toxo IgM. Correlations between maternal and newborn ranked values were evaluated. Results: In both maternal and newborn specimens, we found significantly lower risk of ASD associated with higher levels of Toxo IgG. In addition, point estimates for all comparisons were < 1.0 suggesting an overall pattern of lower immunoglobulin levels associated with higher ASD risk but most did not reach statistical significance. We did not find differences in maternal or newborn specimens comparing children with DD to controls. Discussion: These results are consistent with evidence from our prior study and other published reports indicating that immune factors during early neurodevelopment may be etiologically relevant to ASD. Lowered immunoglobulin levels may represent suboptimal function of the maternal immune system or reduced maternal exposure to common infectious agents. Conclusion: Patterns seen in these selected immunoglobulins may provide clues to mechanisms of early abnormalities in neurodevelopment contributing to ASD. We recommend further study of immunoglobulin profiles in larger samples of linked mother-baby pairs to evaluate possible etiologic relevance.

[1]  A. Mack,et al.  Prevalence of Autism Spectrum Disorders — Autism and Developmental Disabilities Monitoring Network, United States, 2006 , 2011 .

[2]  L. Qi,et al.  Maternal autism-associated IgG antibodies delay development and produce anxiety in a mouse gestational transfer model , 2012, Journal of Neuroimmunology.

[3]  P. Ashwood,et al.  The role of immune dysfunction in the pathophysiology of autism , 2012, Brain, Behavior, and Immunity.

[4]  R. Yolken,et al.  Maternal Cytokine Levels during Pregnancy and Adult Psychosis , 2001, Brain, Behavior, and Immunity.

[5]  I. McKeague,et al.  Elevated Maternal C-Reactive Protein and Autism in a National Birth Cohort , 2012, Molecular Psychiatry.

[6]  Tyrone D. Cannon,et al.  Maternal Exposure to Herpes Simplex Virus and Risk of Psychosis Among Adult Offspring , 2008, Biological Psychiatry.

[7]  S. Chess,et al.  Autism in children with congenital rubella , 1971, Journal of autism and childhood schizophrenia.

[8]  David G. Amaral,et al.  Stereotypies and hyperactivity in rhesus monkeys exposed to IgG from mothers of children with autism , 2008, Brain, Behavior, and Immunity.

[9]  E. G. Stubbs,et al.  Autism and congenital cytomegalovirus , 1984, Journal of autism and developmental disorders.

[10]  E. Deykin,et al.  Viral exposure and autism. , 1979, American journal of epidemiology.

[11]  R. Yolken,et al.  Maternal infections and subsequent psychosis among offspring. , 2001, Archives of general psychiatry.

[12]  Cathleen K. Yoshida,et al.  Maternal Mid-Pregnancy Autoantibodies to Fetal Brain Protein: The Early Markers for Autism Study , 2008, Biological Psychiatry.

[13]  I. Hertz-Picciotto,et al.  Is Maternal Influenza or Fever During Pregnancy Associated with Autism or Developmental Delays? Results from the CHARGE (CHildhood Autism Risks from Genetics and Environment) Study , 2012, Journal of Autism and Developmental Disorders.

[14]  R. Yolken,et al.  Neonatal antibodies to infectious agents and risk of bipolar disorder: a population‐based case–control study , 2011, Bipolar disorders.

[15]  Cathleen K. Yoshida,et al.  Increased midgestational IFN-γ, IL-4 and IL-5 in women bearing a child with autism: A case-control study , 2011, Molecular autism.

[16]  Christina M. Morris,et al.  Childhood serum anti-fetal brain antibodies do not predict autism. , 2009, Pediatric neurology.

[17]  Irva Hertz-Picciotto,et al.  The CHARGE Study: An Epidemiologic Investigation of Genetic and Environmental Factors Contributing to Autism , 2006, Environmental health perspectives.

[18]  Exposure to Prenatal Infection and Risk of Schizophrenia , 2011, Front. Psychiatry.

[19]  P. Markowitz Autism in a child with congenital cytomegalovirus infection , 1983, Journal of autism and developmental disorders.

[20]  C. Rice,et al.  Autism and Developmental Disabilities Monitoring Network Surveillance Year 2000 Principal Investigators , 2012 .

[21]  Christina M. Morris,et al.  Prenatal exposure to antibodies from mothers of children with autism produces neurobehavioral alterations: A pregnant dam mouse model , 2009, Journal of Neuroimmunology.

[22]  D. Schendel,et al.  Autism After Infection, Febrile Episodes, and Antibiotic Use During Pregnancy: An Exploratory Study , 2012, Pediatrics.

[23]  Cathleen K. Yoshida,et al.  Maternal Rh D status, anti-D immune globulin exposure during pregnancy, and risk of autism spectrum disorders. , 2008, American journal of obstetrics and gynecology.

[24]  S. Fatemi,et al.  Viral infection, inflammation and schizophrenia , 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[25]  D. Schendel,et al.  Association of hospitalization for infection in childhood with diagnosis of autism spectrum disorders: a Danish cohort study. , 2010, Archives of pediatrics & adolescent medicine.

[26]  I. Hertz-Picciotto,et al.  Autism: maternally derived antibodies specific for fetal brain proteins. , 2007, Neurotoxicology.

[27]  Kevin G Becker,et al.  Autism, asthma, inflammation, and the hygiene hypothesis. , 2007, Medical hypotheses.

[28]  J. A. Van de Water,et al.  The immune system's role in the biology of autism , 2010, Current opinion in neurology.

[29]  T. Navin,et al.  Toxoplasma gondii infection in the United States: seroprevalence and risk factors. , 2001, American journal of epidemiology.

[30]  P. Patterson,et al.  Maternal infection and immune involvement in autism. , 2011, Trends in molecular medicine.

[31]  A. Blamire,et al.  Maternal neuronal antibodies associated with autism and a language disorder , 2003, Annals of neurology.

[32]  Cathleen K. Yoshida,et al.  Infection in the First 2 Years of Life and Autism Spectrum Disorders , 2007, Pediatrics.

[33]  N. Simister Placental transport of immunoglobulin G. , 2003, Vaccine.

[34]  D. Schendel,et al.  Using maternally reported data to investigate the association between early childhood infection and autism spectrum disorder: the importance of data source. , 2012, Paediatric and perinatal epidemiology.

[35]  C. Lajonchere,et al.  Genetic heritability and shared environmental factors among twin pairs with autism. , 2011, Archives of general psychiatry.

[36]  R. Yolken,et al.  Neonatally measured immunoglobulins and risk of autism , 2010, Autism research : official journal of the International Society for Autism Research.

[37]  L. Lee,et al.  Maternal antibrain antibodies in autism , 2007, Brain, Behavior, and Immunity.

[38]  T. Matsuishi,et al.  Possible Association Between Congenital Cytomegalovirus Infection and Autistic Disorder , 2003, Journal of autism and developmental disorders.